Dermatologic Device Approval by the US Food and Drug Administration
This cross-sectional database study characterizes the postapproval changes to Class III dermatologic devices and evaluates inconsistencies in the use of the premarket approval pathway.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου